Survival analysis, cost-effectiveness and budget impact, in one tool.
Reconstruct patient-level data from digitised Kaplan-Meier curves, extrapolate survival, and run cost-effectiveness with DSA and PSA. Budget impact sits alongside. No code required.
No credit card required · 14-day trial
Built on flexsurv and IPDfromKM. Aligned with NICE TSD14. Founded by health economists in Helsinki.
Who it’s for
Different questions. One platform.
Same reconstruction and fits underneath, four different starting points.
Pharma market access and HEOR
Build an early cost-effectiveness case from trial curves: compare the ICER across price scenarios side by side, and use DSA and PSA to see which inputs drive it.
Consultancies and independent health economists
Replace one-off R scripts with a pipeline that gives the same reconstruction and fits every time, with outputs ready for your Excel model or a partitioned survival model.
HTA bodies, hospitals and health systems
Rerun a submission’s extrapolation and ICER under your own assumptions, then see net budget impact by year and by payer, with bed-days reported separately from cash.
Medtech companies
A budget-impact case for hospital buyers: per-patient device and procedure costs, equipment and programme costs, and avoided care, with adoption ramping year by year.
What this replaces
Keep the judgement. Drop the scripting.
- Results that depend on who last ran the script. The same inputs give the same fits, whoever opens the analysis.
- Fitting distributions one at a time. All seven are fitted in one run and ranked by AIC and BIC.
- Hand-copying coefficients into the CE workbook. Fitted parameters export to Excel or feed the in-app model.
- Reviewers who only ever see the final numbers. Invite read-only viewers, who don’t use a seat.
Product
Everything an evidence team needs.
From a Kaplan-Meier curve to the ICER, with budget impact alongside.
IPD reconstruction from digitised KM curves
Upload digitised Kaplan-Meier coordinates and the numbers at risk. The Guyot algorithm reconstructs patient-level data, then checks it against the published curve and at-risk counts.
Parametric survival models
Fit standard distributions: exponential, Weibull, gamma, log-normal, log-logistic, Gompertz, and generalised gamma. AIC/BIC ranking built in.
Cure models with background mortality
From a cure point you set, survival follows SMR-adjusted general population mortality, for therapies with long-term responders.
Cost-effectiveness
A three-state partitioned survival model built on your fitted curves, with per-state costs and utilities and the ICER up front.
Sensitivity analysis
One-way DSA with a tornado diagram, probabilistic sensitivity analysis that carries survival uncertainty through to the CEAC, and saved scenarios compared side by side.
Budget impact
Net budget impact and percentage change over a multi-year horizon, with current and new market-share scenarios, broken down by year.
Exports for your model and dossier
Excel workbooks with fitted parameters for your CE model, and dossier-ready tables for Word, Excel or the clipboard.
Workspaces for teams
Share analyses with your team as full members or read-only viewers, with a version history of every change.
Cost-effectiveness, budget impact and sensitivity analysis are included from Analyst Pro. Version history is on every plan. Collaborative workspaces are Team and above.
How it works
From a Kaplan-Meier curve to an economic model, in three steps.
Upload curves
Add digitised Kaplan-Meier coordinates and numbers at risk.
Fit and choose
Reconstruct patient-level data, fit seven distributions and rank them by AIC/BIC.
Model and export
Add costs and utilities for the ICER, then export to Excel or Word.
Plans
A single Analyst Pro seat covers survival analysis, cost-effectiveness and budget-impact work.
Analyst Pro
For full health-economic modelling and budget impact.
€5,990 / year
VAT included for personal purchases
Business VAT calculated at checkout
Or €599 per month if billed monthly
14 days free. No credit card required.
Team
For market access teams working on assessments together.
From €36,000 / year
Founding Member pricing available until August 2027. Includes 5 seats; additional seats and scope are priced separately.
Enterprise
For organisations with procurement and security requirements.
Custom pricing
Unlimited seats
Working alone? See the Solo Analyst plan.
Start your free trial today.
No credit card required. Full access for 14 days. Read the docs
LinkedIn